Insulin regulates P-glycoprotein in rat brain microvessel endothelial cells via an insulin receptor-mediated PKC/NF-κB pathway but not a PI3K/Akt pathway-Reference-Cited by-同舟云学术

Insulin regulates P-glycoprotein in rat brain microvessel endothelial cells via an insulin receptor-mediated PKC/NF-κB pathway but not a PI3K/Akt pathway

Published:2009-01 Issue:2-3 Volume:602 Page:277-282
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Liu Haiyan,Yang Huiwen,Wang Dianlei,Liu Yuchun,Liu Xiaodong,Li Yang,Xie Lin,Wang GuangJi

Publisher

Elsevier BV

Subject

Pharmacology

Reference38 articles.

1. Effect of endotoxin on P-glycoprotein mediated biliary and renal excretion of rhodamine-123 in rats;Ando;Antimicrob. Agents Chemother.,2001

2. LY294002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance;Barancík;Eur. J. Pharm. Sci.,2006

3. The IGF-I receptor in cancer research;Baserga;Exp. Cell Res.,1999

4. Substrate competitive inhibitors of IGF-1 receptor kinase;Blum;Biochemistry,2000

5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding;Bradford;Anal. Biochem.,1976

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin and the blood–brain barrier;Vitamins and Hormones;2024

2. Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer’s and Parkinson’s diseases;Tissue Barriers;2023-12-14

3. ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery;Pharmacological Reviews;2023-03-27

4. Identification and mechanism prediction of mulberroside A metabolites in vivo and in vitro of rats using an integrated strategy of UHPLC-Q-Exactive Plus Orbitrap MS and network pharmacology;Frontiers in Chemistry;2022-09-27

5. Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway;Life Sciences;2022-03